Consumer Risk Perception and Recombinant Bovine Growth Hormone: The Case for Labeling Dairy Products Made from Untreated Herd Milk

One of the most controversial animal food-related biotechnology applications has been the Food and Drug Administration's 1993 approval of a synthetic bovine growth hormone, called rbGH. Farmers, producers, policymakers, and consumers debate whether differences exist between rbGH and the natural...

Full description

Saved in:
Bibliographic Details
Published in:Journal of public policy & marketing 1995-10, Vol.14 (2), p.328-330
Main Author: Douthitt, Robin A.
Format: Article
Language:English
Subjects:
Agricultural products
Biotechnology
Consumer behavior
Consumer economics
Consumer goods
Consumer information
Consumer protection
Consumer psychology
Consumers
Dairy industry
Dairy products
Descriptive labeling
Financial risk
Food and drug administration
Food products
Growth hormones
Health risk assessment
Health risks
Labeling
Labels
Milk
Milk production
Milk trade
Perceptions
Policy Watch
Product labeling
Public health
Public officials
Radiation
Regulation
Science
Scientists
Social sciences
Sumer
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:One of the most controversial animal food-related biotechnology applications has been the Food and Drug Administration's 1993 approval of a synthetic bovine growth hormone, called rbGH. Farmers, producers, policymakers, and consumers debate whether differences exist between rbGH and the naturally occurring bovine growth hormone, bGH. The rbGH case study emphasizes the critical role of consumer risk perceptions - and industry's response to those perceptions - by explaining consumer product acceptance. Furthermore, it emphasizes the potential importance of labeling in reducing the perceived risks of new technologies.
ISSN:0743-9156
1547-7207
DOI:10.1177/074391569501400215